S100B and cerebral palsy: In infants with hypoxic-ischemic encephalopathy (HIE), S100B levels are higher in moderate-to-severe compared with mild HIE and correlate with the severity of encephalopathy, extent of MRI injury, and adverse outcomes including cerebral palsy and death30–33.